drugset / Trial / NCT05136378
Selenious Yeast in CLL Patients w/o Indication of Chemotherapy
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the safety and effectiveness of Selenious Yeast Tablets in Chronic Lymphocytic Leukemia Patients without Indication of Chemotherapy
Timeline
- Start
- 2021-11-01
- Primary completion
- 2023-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selenious Yeast | Unknown | 200 ug | — |
| Subject | Selenious Yeast | Unknown | 400 ug | — |